What is it about?
Immunoglobulin A (IgA) nephropathy is a common form of primary glomerular disease and a leading cause of kidney failure. This article discusses new therapies that are being developed to treat this condition, that target the B cell survival factor called APRIL, and discusses recent clinical trial data.
Featured Image
Read the Original
This page is a summary of: Targeting APRIL in the Treatment of IgA Nephropathy, Clinical Journal of the American Society of Nephrology, October 2023, Wolters Kluwer Health,
DOI: 10.2215/cjn.0000000000000338.
You can read the full text:
Contributors
The following have contributed to this page
